
NAOV
Nanovibronix Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
7.3834
Open
7.280
VWAP
6.64
Vol
92.77K
Mkt Cap
5.51M
Low
5.7001
Amount
615.86K
EV/EBITDA(TTM)
--
Total Shares
2.78M
EV
9.07M
EV/OCF(TTM)
--
P/S(TTM)
0.80
NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2019Q4
153.00K
+183.33%
--
--
Estimates Revision
Stock Price
Go Down

-82.68%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Nanovibronix Inc (NAOV.O) is -0.00, compared to its 5-year average forward P/E of -0.70. For a more detailed relative valuation and DCF analysis to assess Nanovibronix Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
-0.70
Current PE
-0.00
Overvalued PE
0.12
Undervalued PE
-1.51
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
6.78
Current PS
1.27
Overvalued PS
18.28
Undervalued PS
-4.72
Financials
Annual
Quarterly
FY2025Q1
YoY :
+11.29%
1.03M
Total Revenue
FY2025Q1
YoY :
+226.06%
-1.85M
Operating Profit
FY2025Q1
YoY :
+324.32%
-2.50M
Net Income after Tax
FY2025Q1
YoY :
+54.26%
-3.98
EPS - Diluted
FY2025Q1
YoY :
+132.41%
-1.35M
Free Cash Flow
FY2025Q1
YoY :
-50.07%
36.00
Gross Profit Margin - %
FY2025Q1
YoY :
+18.02%
-123.48
FCF Margin - %
FY2025Q1
YoY :
+281.28%
-243.41
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
NAOV News & Events
Events Timeline
2025-08-08 (ET)
2025-08-08
09:08:54
NanoVibronix announces reverse stock split

2025-06-24 (ET)
2025-06-24
08:05:34
NanoVibronix to sell two ENvue Navigation Systems to hospital in New York

2025-06-11 (ET)
2025-06-11
08:01:52
NanoVibronix granted patent for pediatric feeding tube guidance system

Sign Up For More Events
Sign Up For More Events
News
9.0
08-10TipRanksUpcoming Stock Splits This Week (August 11 to August 15) – Stay Invested
8.5
07-18NewsfilterNanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock
5.0
06-26NewsfilterNanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation
Sign Up For More News
People Also Watch
FAQ

What is Nanovibronix Inc (NAOV) stock price today?
The current price of NAOV is 6.91 USD — it has decreased -7 % in the last trading day.

What is Nanovibronix Inc (NAOV)'s business?

What is the price predicton of NAOV Stock?

What is Nanovibronix Inc (NAOV)'s revenue for the last quarter?

What is Nanovibronix Inc (NAOV)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Nanovibronix Inc (NAOV)'s fundamentals?

How many employees does Nanovibronix Inc (NAOV). have?
